BR112015022946A8 - Forma de dosagem de cápsula de gelatina macia farmacêutica com goma guar modificada - Google Patents

Forma de dosagem de cápsula de gelatina macia farmacêutica com goma guar modificada

Info

Publication number
BR112015022946A8
BR112015022946A8 BR112015022946A BR112015022946A BR112015022946A8 BR 112015022946 A8 BR112015022946 A8 BR 112015022946A8 BR 112015022946 A BR112015022946 A BR 112015022946A BR 112015022946 A BR112015022946 A BR 112015022946A BR 112015022946 A8 BR112015022946 A8 BR 112015022946A8
Authority
BR
Brazil
Prior art keywords
dosage form
gelatin capsule
soft gelatin
guar gum
modified guar
Prior art date
Application number
BR112015022946A
Other languages
English (en)
Portuguese (pt)
Other versions
BR112015022946A2 (pt
Inventor
Muldoon Brendan
Gerald Loughlin Ryan
Sweeney Gerarde
Karen Boyd Emma
Original Assignee
Warner Chilcott Co Llc
Allergan Pharmaceuticals Int Ltd
Teva Puerto Rico Llc
Allergan Therapeutics LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Chilcott Co Llc, Allergan Pharmaceuticals Int Ltd, Teva Puerto Rico Llc, Allergan Therapeutics LLC filed Critical Warner Chilcott Co Llc
Publication of BR112015022946A2 publication Critical patent/BR112015022946A2/pt
Publication of BR112015022946A8 publication Critical patent/BR112015022946A8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR112015022946A 2013-03-15 2014-03-14 Forma de dosagem de cápsula de gelatina macia farmacêutica com goma guar modificada BR112015022946A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361794906P 2013-03-15 2013-03-15
PCT/US2014/027145 WO2014152269A1 (en) 2013-03-15 2014-03-14 Pharmaceutical soft gelatin capsule dosage form with modified guar gum

Publications (2)

Publication Number Publication Date
BR112015022946A2 BR112015022946A2 (pt) 2017-07-18
BR112015022946A8 true BR112015022946A8 (pt) 2022-11-29

Family

ID=50588879

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015022946A BR112015022946A8 (pt) 2013-03-15 2014-03-14 Forma de dosagem de cápsula de gelatina macia farmacêutica com goma guar modificada

Country Status (14)

Country Link
US (3) US9795569B2 (https=)
EP (2) EP3187170A1 (https=)
JP (3) JP6335270B2 (https=)
KR (1) KR20150131070A (https=)
CN (2) CN105307634B (https=)
AU (2) AU2014239994B2 (https=)
BR (1) BR112015022946A8 (https=)
CA (1) CA2906633C (https=)
ES (1) ES2619121T3 (https=)
HK (1) HK1218622A1 (https=)
IL (1) IL241377B (https=)
MX (2) MX364440B (https=)
RU (1) RU2676480C2 (https=)
WO (1) WO2014152269A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2906633C (en) * 2013-03-15 2021-11-30 Warner Chilcott Company, Llc Pharmaceutical soft gelatin capsule dosage form with modified guar gum
ES2787220T3 (es) 2015-03-26 2020-10-15 Patheon Softgels Inc Cápsulas blandas llenas de líquido
JP2017214299A (ja) * 2016-05-30 2017-12-07 ライオン株式会社 半固形製剤及びその製造方法
CN116916895A (zh) * 2020-11-13 2023-10-20 辉瑞公司 他拉唑帕尼软明胶胶囊剂型
CA3201467A1 (en) * 2020-11-13 2022-05-19 Pfizer Inc. Talazoparib soft gelatin capsule dosage form
CN116531444B (zh) * 2023-07-06 2023-10-10 健码制药（广东）有限公司 镇咳清肺软胶囊及其制备工艺

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4708834A (en) 1986-05-01 1987-11-24 Pharmacaps, Inc. Preparation of gelatin-encapsulated controlled release composition
US5102666A (en) 1990-09-11 1992-04-07 Oramed, Inc. Calcium polycarbophil controlled release composition and method
FR2739558B1 (fr) * 1995-10-05 1997-11-28 Innothera Lab Sa Forme galenique unitaire pour hormonotherapie locale de la secheresse vaginale
IT1275816B1 (it) 1995-10-27 1997-10-17 Montefarmaco Spa Composizioni farmaceutiche solide per uso vaginale
WO1997033568A1 (en) 1996-03-12 1997-09-18 Novartis Ag Filled gelatin capsules having a reduced degree of cross-linking
US5919481A (en) * 1996-06-28 1999-07-06 Ncneil-Ppc, Inc. Fill material for soft gelatin pharmaceutical dosage form
US6024980A (en) * 1996-06-28 2000-02-15 Mcneil-Ppc, Inc. Multiphase soft gelatin dosage form
US5989535A (en) 1997-08-15 1999-11-23 Soma Technologies Polymeric bioadhesive emulsions and suspensions and methods of treatment
IN188719B (https=) * 1997-09-08 2002-11-02 Panacea Biotec Ltd
US6187747B1 (en) * 1997-09-08 2001-02-13 Panacea Biotech Limited Pharmaceutical composition comprising cyclosporin
US7374779B2 (en) * 1999-02-26 2008-05-20 Lipocine, Inc. Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
US6251426B1 (en) * 1999-09-02 2001-06-26 Banner Pharmacaps, Inc. Ibuprofen-containing softgels
US20040131670A1 (en) * 2001-04-17 2004-07-08 Ping Gao Pellicle-resistant gelatin capsule
FR2843304B1 (fr) * 2002-08-07 2005-12-16 Ricarimpex Extraits de sangsues pour stents
US20070066837A1 (en) 2003-02-18 2007-03-22 Ahmed Kamal Podophyllotoxin derivatives as antitumor agents
KR100570450B1 (ko) * 2003-09-25 2006-04-12 한국유나이티드제약 주식회사 가용성 로바스타틴의 연질캡슐제 조성물 및 그의 제조방법
US20050142185A1 (en) * 2003-12-29 2005-06-30 Beleno Alfredo B. Softgel formulations of bisphosphonates bone resorption inhibitors
CN1906206A (zh) 2004-01-15 2007-01-31 沃纳奇尔科特公司 雌二醇的二－甾族前体药物
CA2553816A1 (en) 2004-01-15 2005-08-04 Warner Chilcott Company, Inc. Di-steroidal prodrugs of ethinyl estradiol
US20060110415A1 (en) * 2004-11-22 2006-05-25 Bioderm Research Topical Delivery System for Cosmetic and Pharmaceutical Agents
US7485323B2 (en) 2005-05-31 2009-02-03 Gelita Ag Process for making a low molecular weight gelatine hydrolysate and gelatine hydrolysate compositions
CA2612380C (en) 2005-06-16 2017-06-06 Warner Chilcott Company, Inc. Estrogen compositions for vaginal administration
EP1910401A2 (en) 2005-07-12 2008-04-16 Warner Chilcott Company, Inc. 3-ester prodrugs of ethynylestradiol
CA2610481A1 (en) 2005-07-12 2007-01-18 Warner Chilcott Company, Inc. 3-ester prodrugs of estradiol
US7468970B2 (en) 2005-10-24 2008-12-23 Honeywell International Inc. Routing of mobile agents in a network
CA2627292C (en) * 2005-10-26 2012-04-17 Banner Pharmacaps, Inc. Hydrophilic vehicle-based dual controlled release matrix system
WO2007056424A2 (en) 2005-11-07 2007-05-18 Penwest Pharmaceuticals, Co. Controlled-release emulsion compositions
WO2007066837A1 (en) 2005-12-06 2007-06-14 Lg Household & Health Care Ltd. Delivery system for tooth whitening component using in situ gelling
JP2009526040A (ja) 2006-02-10 2009-07-16 エル・ジー ハウスホールド アンド ヘルスケア リミティッド 同時溶解及びゲル化錠剤型の口腔衛生組成物
US20080090569A1 (en) 2006-10-13 2008-04-17 At&T Knowledge Ventures, L.P. Method and apparatus for performing signal processing in an ip multimedia subsystem network
US20080122993A1 (en) 2006-11-29 2008-05-29 Sanyo Electric Co., Ltd. Television image receiver
EP2114380A1 (en) 2007-01-25 2009-11-11 Panacea Biotec Ltd. Modified release pharmaceutical composition and a process of making the same
WO2008122993A1 (en) 2007-04-09 2008-10-16 Panacea Biotec Limited Controlled release formulation of coated microparticles
CN101971130A (zh) 2008-03-26 2011-02-09 十字科技股份有限公司 光学指向装置及具有该光学指向装置的便携式电子装置
CN101474167A (zh) * 2009-01-23 2009-07-08 西安德天药业股份有限公司 雌二醇阴道用胶囊的制备方法
US20110003000A1 (en) 2009-07-06 2011-01-06 Femmepharma Holding Company, Inc. Transvaginal Delivery of Drugs
WO2011018800A2 (en) 2009-08-13 2011-02-17 Fdc Limited A novel in-situ gel forming solution for ocular drug delivery
CA2906633C (en) * 2013-03-15 2021-11-30 Warner Chilcott Company, Llc Pharmaceutical soft gelatin capsule dosage form with modified guar gum

Also Published As

Publication number Publication date
ES2619121T3 (es) 2017-06-23
JP6704430B2 (ja) 2020-06-03
KR20150131070A (ko) 2015-11-24
US10744096B2 (en) 2020-08-18
JP2018140998A (ja) 2018-09-13
US20180036252A1 (en) 2018-02-08
CN105307634A (zh) 2016-02-03
MX2019004554A (es) 2019-08-05
AU2014239994A1 (en) 2015-10-08
IL241377A0 (en) 2015-11-30
EP2950781B1 (en) 2016-12-21
WO2014152269A1 (en) 2014-09-25
US20150044285A1 (en) 2015-02-12
CA2906633A1 (en) 2014-09-25
MX2015012057A (es) 2016-05-05
AU2014239994B2 (en) 2019-01-24
JP2020147569A (ja) 2020-09-17
US9820946B2 (en) 2017-11-21
EP3187170A1 (en) 2017-07-05
JP2016513684A (ja) 2016-05-16
EP2950781A1 (en) 2015-12-09
IL241377B (en) 2019-08-29
BR112015022946A2 (pt) 2017-07-18
CN105307634B (zh) 2020-03-10
US9795569B2 (en) 2017-10-24
CA2906633C (en) 2021-11-30
NZ712280A (en) 2021-01-29
MX364440B (es) 2019-04-26
AU2019200116A1 (en) 2019-01-31
CN111374959A (zh) 2020-07-07
JP6335270B2 (ja) 2018-05-30
HK1218622A1 (zh) 2017-03-03
RU2015137612A (ru) 2017-04-24
US20140271838A1 (en) 2014-09-18
RU2676480C2 (ru) 2018-12-29

Similar Documents

Publication Publication Date Title
CL2018000495A1 (es) Envase blíster
BR112015022946A8 (pt) Forma de dosagem de cápsula de gelatina macia farmacêutica com goma guar modificada
MX2017001512A (es) Compuestos activos hacia bromodominios.
MX2015011163A (es) Capsula entericas blandas que no contienen gelatina.
CL2016002020A1 (es) Composición farmacéutica que consta de eritrocitos que encapsulan una encima plp dependiente y su cofactor
CL2015002148A1 (es) Formulaciones farmacéuticas resistentes a la manipulación indebida
AR098168A1 (es) Formulación estable de insulina glulisina
EA202090085A1 (ru) Устройства и способы для переполнения контейнеров с лекарственным средством
BR112016014880A2 (pt) Composição farmacêutica incluindo palonosetron
AR092151A1 (es) Preparacion farmaceutica solida que contiene levotiroxina
EA201600387A1 (ru) Дисперсная система доставки лекарственного вещества
MX2015012075A (es) Forma de dosis farmaceutica de capsula de gelatina blanda.
EP3318217A4 (en) PROTHESIS PACKAGING, PROSTHESIS AND PROSTHESIS WITH PACKAGING
CL2015000610A1 (es) Derivados de isoxazolidina
EP3957293A4 (en) SEALED CONTAINER FOR MEDICATION
MX2019006909A (es) Composicion para el cuidado bucal.
PH12014502170B1 (en) Drug composition and soft capsule drug sealing the drug composition
UA75723U (uk) Лікарський засіб седативної та спазмолітичної дії у формі м'яких желатинових капсул
IN2013MU02015A (https=)
TR201722934A2 (tr) Di̇klofenak potasyum i̇çeren farmasöti̇k bi̇leşi̇m
MX388684B (es) Metodo de administracion de compuestos donadores de nitroxilo.
UA107884C2 (en) Combined anti-tuberculosis drug
CO7250121A1 (es) Composición nutracéutica de goma de mascar en polvo
TH158486A (th) องค์ประกอบของยาปฏิชีวนะเซฟโทโลเซน
BR112017017774A2 (pt) composto, composição farmacêutica e método para fabricar um medicamento

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B25A Requested transfer of rights approved

Owner name: TEVA PUERTO RICO LLC (PR)

B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements
B25A Requested transfer of rights approved

Owner name: ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED (IE)

B25A Requested transfer of rights approved

Owner name: ALLERGAN THERAPEUTICS LLC (US)

B25E Requested change of name of applicant rejected

Owner name: ALLERGAN THERAPEUTICS LLC (US)

Free format text: INDEFERIDO O PEDIDO DE ALTERACAO DE NOME CONTIDO NA PETICAO 870220023194 DE17/03/2022 DEVIDO AO DESPACHO PUBLICADO NA RPI 2703 DE 25/10/2022.